Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 6.85
-0.15 (-2.14%)
Mar 4, 2026, 1:40 PM CST
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 1.03 billion as of March 4, 2026. Its market cap has decreased by -38.87% in one year.
Market Cap
1.03B
Enterprise Value
833.52M
Revenue
47.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.85
Market Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 1.03B, a decrease of -81.49%. That is a compound annual growth rate of -12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.02B | -9.09% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.36B |
| Meribank Biotech | 1.34B |
| GeneReach Biotechnology | 1.17B |
| Lukas Biomedical | 1.13B |
| Level Biotechnology | 1.08B |
| TCI GENE | 1.01B |
| Taiwan Advance Bio-Pharmaceutical | 963.00M |
| NatureWise Biotech & Medicals | 944.75M |